Effects of RNAi-mediated gene silencing of LRIG3 expression on cell cycle and survival of glioma cells

Abstract

The effects of RNAi-mediated gene silencing of LRIG3 expression on cell cycle and survival of human glioma cell line GL15 and the possible mechanisms were explored. The plasmids pGenesil2-LRIG3-shRNA1 and pGenesil2-LRIG3-shRNA2 were transfected into GL15 glioma cells respectively by using Metafectine, and the transfected cells that stably suppressed LRIG3 expression were selected by G418. The control cells were transfected with negative control shRNA. The changes in LRIG3 mRNA and protein levels were measured by RT-PCR and Western blot. The apoptosis rate and cell cycle were analyzed by flow cytometry. As compared with the negative shRNA-transfected GL15 cells, LRIG3 mRNA expression in GL15 cells transfected with pGenesil2-LRIG3-shRNA1 and pGenesil2-LRIG3-shRNA2 was silenced by 52.4%, 63.8%, and LRIG3 protein expression was reduced by 50.9% and 67.4% respectively. The LRIG3-specific siRNA transfected cells had higher proliferation rate than control cells. Cell cycle analysis showed that silencing LRIG3 increased the percentage of G₂/M phase cells and the proliferation index significantly (P<0.01). Silencing LRIG3 could inhibit the apoptosis of GL15 cells (P<0.05). These findings suggest that the siRNA targeting LRIG3 gene shows a dramatic inhibitory effect on RNA transcription and protein expression, then promoting the proliferation of GL15 cells, arresting GL15 cells in G₂/M phase, and suppressing apoptosis of GL15 cells.

Keywords

glioma / LRIG3 / cell cycle / cell proliferation / cell apoptosis

References

[1] GuoD., HolmlundC., HenrikssonR., et al. . The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues, and a homolog in Ascidiacea. Genomics, 2004, 84: 157-165

[2] GuoD., NilssonJ., HaapasaloH., et al. . Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors. Acta Neuropathol (Berl), 2006, 111: 238-246

[3] NilssonJ., VallboC., GuoD., et al. . Cloning, characterization, and expression of human LIG1. Biochem Biophys Res Commun, 2001, 284: 1155-1161

[4] HolmlundC., NilssonJ., GuoD., et al. . Characterization and tissue-specific expression of human LRIG2. Gene, 2004, 332: 35-43

[5] SuzukiY., SatoN., TohyamaM., et al. . cDNA cloning of a novel membrane glycoprotein that is expressed specifically in glial cells in the mouse brain. LIG-1, a protein with leucine-rich repeats and immunoglobulin-like domains. J Biol Chem, 1996, 271: 22 522-22 527

[6] HedmanH., NilssonJ., GuoD., et al. . Is LRIG1 a tumor suppressor gene at chromosome 3p14.3?. Acta Oncol, 2002, 41: 352-354

[7] SuzukiY., MiuraH., TanemuraA., et al. . Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia. FEBS Lett, 2002, 521: 67-71

[8] NilssonJ., StarefeldtA., HenrikssonR., et al. . LRIG1 protein in human cells and tissues. Cell Tissue Res, 2003, 312: 65-71

[9] FireA., XuS.Q., MontgomeryM.K., et al. . Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 1998, 391(6669): 806-811

[10] NovinaC.D., SharpP.A.. The RNAi revolution. Nature, 2004, 430(6995): 161-164

[11] BrummelkampT. R., BernardsR., AgamiR.. A system for stable expression short interfering RNAs in mammalian cells. Science, 2002, 296(5567): 550-553

[12] HannonG.J.. RNA interference. Nature, 2002, 418(6894): 244-251

[13] VermesI., HaanenC., ReutelingspergerC.. Flow cytometry of apoptotic cell death. J Immunol Methods, 2000, 243: 167-190

[14] VermesI., HaanenC., Steffens-NakkenH., et al. . A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods, 1995, 184: 39-51

[15] DarzynkiewiczZ., BrunoS., Del BinoG., et al. . Features of apoptotic cells measured by flow cytometry. Cytometry, 1992, 13: 795-808

[16] van EngelandM., NielandL. J., RamaekersF. C., et al. . Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry, 1998, 31: 1-9

[17] OrmerodM.G.. The study of apoptotic cells by flow cytometry. Leukemia, 1998, 12: 1013-1025

[18] DarzynkiewiczZ., LiX., GongJ.. Assays of cell viability: discrimination of cells dying by apoptosis. Methods Cell Biol, 1994, 41: 15-38

[19] DarzynkiewiczZ., BednerE.. Analysis of apoptotic cells by flow and laser scanning cytometry. Methods Enzymol, 2000, 322: 18-39

[20] HomburgC.H., de HaasM., von dem BorneA.E., et al. . Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood, 1995, 85: 532-540

[21] GuoD.S., HanL., ShuK., et al. . Down-regulation of leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line. J Huazhong Univ Sci Technol (Med Sci), 2007, 27(1): 91-94